Literature DB >> 1678762

Nosocomial infections: cockroaches as possible vectors of drug-resistant Klebsiella.

R Fotedar1, U Banerjee, J C Samantray, E Nayar, A Verma.   

Abstract

The possibility that hospital cockroaches may act as vectors of drug-resistant Klebsiella spp. was investigated during Nov 1985 to April 1989, at the All India Institute of Medical Sciences (AIIMS) hospital. Klebsiella spp. (majority Klebsiella pneumoniae) were isolated from 28.3% of hospital cockroaches and 28.1% of infected wounds of patients. Most of Klebsiella isolates from patients (96.3%), and hospital cockroaches (85.9%) showed multiple drug resistance to four or more antimicrobials. Similar strains of Klebsiella spp. were encountered among patients and hospital cockroaches. These findings suggest that hospital cockroaches may act as vectors of drug-resistant Klebsiella spp. and may contribute to the epidemiology of nosocomial infections.

Entities:  

Mesh:

Year:  1991        PMID: 1678762     DOI: 10.1016/0195-6701(91)90161-z

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  3 in total

1.  Prevalence and Antibiotic Resistance of Gram-Negative Pathogenic Bacteria Species Isolated from Periplaneta americana and Blattella germanica in Varanasi, India.

Authors:  D Leshan Wannigama; Rishabh Dwivedi; Alireza Zahraei-Ramazani
Journal:  J Arthropod Borne Dis       Date:  2013-12-18       Impact factor: 1.198

2.  INVESTIGATION OF BACTERIOLOGICAL INFECTIONS OF THE AMERICAN COCKROACHES IN PAVEH CITY, KERMANSHAH PROVINCE.

Authors:  Sirvan Sayyad; Ahmad Vahabi; Boshra Vahabi; Mahnaz Sayyadi; Shahnaz Haji Sahne
Journal:  Mater Sociomed       Date:  2016-01-30

3.  Cockroaches as a Source of High Bacterial Pathogens with Multidrug Resistant Strains in Gondar Town, Ethiopia.

Authors:  Feleke Moges; Setegn Eshetie; Mengistu Endris; Kahsay Huruy; Dagnachew Muluye; Tigist Feleke; Fisha G/Silassie; Getenet Ayalew; Raja Nagappan
Journal:  Biomed Res Int       Date:  2016-06-02       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.